rHEALTH Technology Receives Notice of Allowance for New U.S. Patent Covering Small Volume Sample Consumable and Loader
CAMBRIDGE, Mass., Oct. 4, 2018 /PRNewswire-iReach/ — rHEALTH LLC, an innovative digital health solutions company, announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. Patent Application No. 14/645,388, entitled “Sample Consumable and Loader”, filed by its affiliate DNA Medicine Institute (DMI).
The patent application covers a microvolume sample consumable and loader designed to enhance reproducibility and simplify sample loading, offering improved ease-of-use for point-of-care testing. A Notice of Allowance indicates that the USPTO has completed its review, with the patent expected to be issued within two months.
“This Notice of Allowance represents an important milestone as we continue executing our patent strategy and advancing portable diagnostic and monitoring technologies,” said Dr. Eugene Y. Chan, Founder and CEO. “This innovation enables precise handling of small-volume samples, making advanced testing possible both at home and in clinical settings.”
About rHEALTH
rHEALTH is a digital health solutions company focused on creating integrated technologies that transform healthcare. Its innovations include:
rHEALTH Diagnostic Platform – enables multiple laboratory test classes from a single small-volume blood sample at the point-of-care.
SKYE Sensor – a wireless wearable providing real-time, comprehensive vital sign monitoring.
CHAS – a user-friendly mobile application supporting health management.
For more information, visit www.rhealth.com.
About DNA Medicine Institute
DNA Medicine Institute (DMI), rHEALTH’s affiliate, is a biomedical incubator dedicated to advancing patient care, alleviating human suffering, and treating disease through innovation. Supported by NASA, NIH, and the Bill & Melinda Gates Foundation, DMI leverages interdisciplinary science and engineering expertise to solve complex biomedical challenges.
For more information, visit www.dnamedinstitute.com.
Media Contact:
John Adamou
Vice President, Corporate & Business Development / Media Relations
(617) 999-8395
pr@rhealth.com